VALOR: Vaginal Atrophy & Long-term Observation of Recovery

Inclusion Criteria:

• Diagnosed atrophic vaginitis, lichen sclerosus, lichen simplex chronicus or lichenplanus

• Continuous vulvovaginal symptoms

• Access to smartphone and tablet, laptop or computer

• Access to a valid email address

Exclusion Criteria:

• Unable to provide informed consent

• Patient unable to apply topical device

• Allergy or intolerance to ingredients or excipients of the formulation of studiedproducts

• Systemic hormonal therapy started less than 30 days before baseline

• Systemic corticosteroids ongoing treatment or used within the last 30 days beforebaseline

• Ongoing topical HRT or corticosteroid treatment for the indication underinvestigation

• Topical HRT or corticosteroid treatment used for the indication under investigationwithin the last 30 days before baseline